Kroeger, Nils <br/><br/>
Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy.  [electronic resource] 

 -  European urology  Jun 2014 
 - 1086-92 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2013.07.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy<br/>Neoplasm Grading<br/>Nephrectomy<br/>Retrospective Studies<br/>Survival Rate<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Time Factors<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors